On Monday, Applied Therapeutics Inc (NASDAQ: APLT) was -7.81% drop from the session before settling in for the closing price of $0.11. A 52-week range for APLT has been $0.10 – $1.50.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 26.57%. When this article was written, the company’s average yearly earnings per share was at 29.93%. With a float of $133.23 million, this company’s outstanding shares have now reached $144.30 million.
Applied Therapeutics Inc (APLT) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Applied Therapeutics Inc stocks. The insider ownership of Applied Therapeutics Inc is 7.67%, while institutional ownership is 65.69%. The most recent insider transaction that took place on Dec 16 ’25, was worth 4,816. In this transaction Director of this company sold 43,000 shares at a rate of $0.11, taking the stock ownership to the 65,000 shares. Before that another transaction happened on Dec 16 ’25, when Company’s Director proposed sale 43,000 for $0.22, making the entire transaction worth $9,331.
Applied Therapeutics Inc (APLT) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted 0.33 earnings per share (EPS) during the time that was better than consensus figure (set at -0.17) by 0.5. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 29.93% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 33.95% during the next five years compared to 26.57% growth over the previous five years of trading.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
You can see what Applied Therapeutics Inc (APLT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.96. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.10, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.43 in one year’s time.
Technical Analysis of Applied Therapeutics Inc (APLT)
The latest stats from [Applied Therapeutics Inc, APLT] show that its last 5-days average volume of 13.18 million was superior to 5.79 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 29.15%.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 0.36%, which indicates a significant decrease from 3.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0173 in the past 14 days, which was lower than the 0.0824 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5579, while its 200-day Moving Average is $0.5047. Now, the first resistance to watch is $0.1159. This is followed by the second major resistance level at $0.1267. The third major resistance level sits at $0.1327. If the price goes on to break the first support level at $0.0991, it is likely to go to the next support level at $0.0931. Assuming the price breaks the second support level, the third support level stands at $0.0823.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
There are 144,301K outstanding shares of the company, which has a market capitalization of 15.15 million. As of now, sales total 460 K while income totals -105,620 K. Its latest quarter income was 1,000 K while its last quarter net income were -18,990 K.
